Cargando…
Correction to: Ganglioglioma with adverse clinical outcome and atypical histopathological features were defined by alterations in PTPN11/KRAS/NF1 and other RAS-/MAP-Kinase pathway genes
| Autores principales: | , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer Berlin Heidelberg
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10175382/ https://www.ncbi.nlm.nih.gov/pubmed/37115209 http://dx.doi.org/10.1007/s00401-023-02577-x |
| _version_ | 1785040202852466688 |
|---|---|
| author | Hoffmann, Lucas Coras, Roland Kobow, Katja López-Rivera, Javier A. Lal, Dennis Leu, Costin Najm, Imad Nürnberg, Peter Herms, Jochen Harter, Patrick N. Bien, Christian G. Kalbhenn, Thilo Müller, Markus Pieper, Tom Hartlieb, Till Kudernatsch, Manfred Hamer, Hajo Brandner, Sebastian Rössler, Karl Blümcke, Ingmar Jabari, Samir |
| author_facet | Hoffmann, Lucas Coras, Roland Kobow, Katja López-Rivera, Javier A. Lal, Dennis Leu, Costin Najm, Imad Nürnberg, Peter Herms, Jochen Harter, Patrick N. Bien, Christian G. Kalbhenn, Thilo Müller, Markus Pieper, Tom Hartlieb, Till Kudernatsch, Manfred Hamer, Hajo Brandner, Sebastian Rössler, Karl Blümcke, Ingmar Jabari, Samir |
| author_sort | Hoffmann, Lucas |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10175382 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Springer Berlin Heidelberg |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-101753822023-05-13 Correction to: Ganglioglioma with adverse clinical outcome and atypical histopathological features were defined by alterations in PTPN11/KRAS/NF1 and other RAS-/MAP-Kinase pathway genes Hoffmann, Lucas Coras, Roland Kobow, Katja López-Rivera, Javier A. Lal, Dennis Leu, Costin Najm, Imad Nürnberg, Peter Herms, Jochen Harter, Patrick N. Bien, Christian G. Kalbhenn, Thilo Müller, Markus Pieper, Tom Hartlieb, Till Kudernatsch, Manfred Hamer, Hajo Brandner, Sebastian Rössler, Karl Blümcke, Ingmar Jabari, Samir Acta Neuropathol Correction Springer Berlin Heidelberg 2023-04-28 2023 /pmc/articles/PMC10175382/ /pubmed/37115209 http://dx.doi.org/10.1007/s00401-023-02577-x Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
| spellingShingle | Correction Hoffmann, Lucas Coras, Roland Kobow, Katja López-Rivera, Javier A. Lal, Dennis Leu, Costin Najm, Imad Nürnberg, Peter Herms, Jochen Harter, Patrick N. Bien, Christian G. Kalbhenn, Thilo Müller, Markus Pieper, Tom Hartlieb, Till Kudernatsch, Manfred Hamer, Hajo Brandner, Sebastian Rössler, Karl Blümcke, Ingmar Jabari, Samir Correction to: Ganglioglioma with adverse clinical outcome and atypical histopathological features were defined by alterations in PTPN11/KRAS/NF1 and other RAS-/MAP-Kinase pathway genes |
| title | Correction to: Ganglioglioma with adverse clinical outcome and atypical histopathological features were defined by alterations in PTPN11/KRAS/NF1 and other RAS-/MAP-Kinase pathway genes |
| title_full | Correction to: Ganglioglioma with adverse clinical outcome and atypical histopathological features were defined by alterations in PTPN11/KRAS/NF1 and other RAS-/MAP-Kinase pathway genes |
| title_fullStr | Correction to: Ganglioglioma with adverse clinical outcome and atypical histopathological features were defined by alterations in PTPN11/KRAS/NF1 and other RAS-/MAP-Kinase pathway genes |
| title_full_unstemmed | Correction to: Ganglioglioma with adverse clinical outcome and atypical histopathological features were defined by alterations in PTPN11/KRAS/NF1 and other RAS-/MAP-Kinase pathway genes |
| title_short | Correction to: Ganglioglioma with adverse clinical outcome and atypical histopathological features were defined by alterations in PTPN11/KRAS/NF1 and other RAS-/MAP-Kinase pathway genes |
| title_sort | correction to: ganglioglioma with adverse clinical outcome and atypical histopathological features were defined by alterations in ptpn11/kras/nf1 and other ras-/map-kinase pathway genes |
| topic | Correction |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10175382/ https://www.ncbi.nlm.nih.gov/pubmed/37115209 http://dx.doi.org/10.1007/s00401-023-02577-x |
| work_keys_str_mv | AT hoffmannlucas correctiontogangliogliomawithadverseclinicaloutcomeandatypicalhistopathologicalfeaturesweredefinedbyalterationsinptpn11krasnf1andotherrasmapkinasepathwaygenes AT corasroland correctiontogangliogliomawithadverseclinicaloutcomeandatypicalhistopathologicalfeaturesweredefinedbyalterationsinptpn11krasnf1andotherrasmapkinasepathwaygenes AT kobowkatja correctiontogangliogliomawithadverseclinicaloutcomeandatypicalhistopathologicalfeaturesweredefinedbyalterationsinptpn11krasnf1andotherrasmapkinasepathwaygenes AT lopezriverajaviera correctiontogangliogliomawithadverseclinicaloutcomeandatypicalhistopathologicalfeaturesweredefinedbyalterationsinptpn11krasnf1andotherrasmapkinasepathwaygenes AT laldennis correctiontogangliogliomawithadverseclinicaloutcomeandatypicalhistopathologicalfeaturesweredefinedbyalterationsinptpn11krasnf1andotherrasmapkinasepathwaygenes AT leucostin correctiontogangliogliomawithadverseclinicaloutcomeandatypicalhistopathologicalfeaturesweredefinedbyalterationsinptpn11krasnf1andotherrasmapkinasepathwaygenes AT najmimad correctiontogangliogliomawithadverseclinicaloutcomeandatypicalhistopathologicalfeaturesweredefinedbyalterationsinptpn11krasnf1andotherrasmapkinasepathwaygenes AT nurnbergpeter correctiontogangliogliomawithadverseclinicaloutcomeandatypicalhistopathologicalfeaturesweredefinedbyalterationsinptpn11krasnf1andotherrasmapkinasepathwaygenes AT hermsjochen correctiontogangliogliomawithadverseclinicaloutcomeandatypicalhistopathologicalfeaturesweredefinedbyalterationsinptpn11krasnf1andotherrasmapkinasepathwaygenes AT harterpatrickn correctiontogangliogliomawithadverseclinicaloutcomeandatypicalhistopathologicalfeaturesweredefinedbyalterationsinptpn11krasnf1andotherrasmapkinasepathwaygenes AT bienchristiang correctiontogangliogliomawithadverseclinicaloutcomeandatypicalhistopathologicalfeaturesweredefinedbyalterationsinptpn11krasnf1andotherrasmapkinasepathwaygenes AT kalbhennthilo correctiontogangliogliomawithadverseclinicaloutcomeandatypicalhistopathologicalfeaturesweredefinedbyalterationsinptpn11krasnf1andotherrasmapkinasepathwaygenes AT mullermarkus correctiontogangliogliomawithadverseclinicaloutcomeandatypicalhistopathologicalfeaturesweredefinedbyalterationsinptpn11krasnf1andotherrasmapkinasepathwaygenes AT piepertom correctiontogangliogliomawithadverseclinicaloutcomeandatypicalhistopathologicalfeaturesweredefinedbyalterationsinptpn11krasnf1andotherrasmapkinasepathwaygenes AT hartliebtill correctiontogangliogliomawithadverseclinicaloutcomeandatypicalhistopathologicalfeaturesweredefinedbyalterationsinptpn11krasnf1andotherrasmapkinasepathwaygenes AT kudernatschmanfred correctiontogangliogliomawithadverseclinicaloutcomeandatypicalhistopathologicalfeaturesweredefinedbyalterationsinptpn11krasnf1andotherrasmapkinasepathwaygenes AT hamerhajo correctiontogangliogliomawithadverseclinicaloutcomeandatypicalhistopathologicalfeaturesweredefinedbyalterationsinptpn11krasnf1andotherrasmapkinasepathwaygenes AT brandnersebastian correctiontogangliogliomawithadverseclinicaloutcomeandatypicalhistopathologicalfeaturesweredefinedbyalterationsinptpn11krasnf1andotherrasmapkinasepathwaygenes AT rosslerkarl correctiontogangliogliomawithadverseclinicaloutcomeandatypicalhistopathologicalfeaturesweredefinedbyalterationsinptpn11krasnf1andotherrasmapkinasepathwaygenes AT blumckeingmar correctiontogangliogliomawithadverseclinicaloutcomeandatypicalhistopathologicalfeaturesweredefinedbyalterationsinptpn11krasnf1andotherrasmapkinasepathwaygenes AT jabarisamir correctiontogangliogliomawithadverseclinicaloutcomeandatypicalhistopathologicalfeaturesweredefinedbyalterationsinptpn11krasnf1andotherrasmapkinasepathwaygenes |